Detalles de la búsqueda
1.
Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: A proof-of-concept study.
J Med Virol
; 95(7): e28933, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37403897
2.
Features of cytomegalovirus DNAemia and virus-specific T-cell responses in allogeneic hematopoietic stem-cell transplant recipients during prophylaxis with letermovir.
Transpl Infect Dis
; 25(2): e14021, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36748748
3.
Impact of cytomegalovirus immunodominant HLA-I donor-recipient matching on the incidence and features of virus DNAemia and virus-specific T-cell immune reconstitution in unmanipulated haploidentical hematopoietic stem cell transplantation.
Transpl Infect Dis
; 25(3): e14065, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37120821
4.
Biomarker profile predicts clinical efficacy of extracorporeal photopheresis in steroid-resistant acute and chronic graft-vs-host disease after allogenic hematopoietic stem cell transplant.
J Clin Apher
; 36(5): 697-710, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34185332
5.
Impact of clinical features, cytogenetics, genetic mutations, and methylation dynamics of CDKN2B and DLC-1 promoters on treatment response to azacitidine.
Ann Hematol
; 99(3): 527-537, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31989250
6.
Incidence and clinical correlates of NFE2 mutations in myeloid neoplasms.
Br J Haematol
; 2024 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38840560
7.
Kinetics of inflammatory biomarkers in plasma predict the occurrence and features of cytomegalovirus DNAemia episodes in allogeneic hematopoietic stem cell transplant recipients.
Med Microbiol Immunol
; 208(3-4): 405-414, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30911925
8.
Immunobiology of cytomegalovirus infection in patients with haematological malignancies undergoing treatment with small molecule inhibitors.
Br J Haematol
; 200(6): e58-e61, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36652997
9.
Therapy-related acute myeloid leukemia developing 14â¯years after allogeneic hematopoietic stem cell transplantation, from a persistent R882H-DNMT3A mutated clone of patient origin.
Exp Mol Pathol
; 105(1): 139-143, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30017658
10.
Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: A real-world comparison.
Mycoses
; 61(3): 206-212, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29125660
11.
IL28B genetic variation and cytomegalovirus-specific T-cell immunity in allogeneic stem cell transplant recipients.
J Med Virol
; 89(4): 685-695, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27591738
12.
Impact of cytomegalovirus DNAemia on overall and non-relapse mortality in allogeneic stem cell transplant recipients.
Transpl Infect Dis
; 19(4)2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28471073
13.
Cytomegalovirus-specific T-cell immunity and DNAemia in patients with chronic lymphocytic leukaemia undergoing treatment with ibrutinib.
Br J Haematol
; 195(4): 637-641, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34402042
14.
Risk factors for non-melanoma skin cancer in patients with essential thrombocythemia and polycythemia vera.
Eur J Haematol
; 96(3): 285-90, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25996073
15.
Lack of evidence for a reciprocal interaction between bacterial and cytomegalovirus infection in the allogeneic stem cell transplantation setting.
Transpl Int
; 29(11): 1196-1204, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27529151
16.
Plasma metabolomics profiling for the prediction of cytomegalovirus DNAemia and analysis of virushost interaction in allogeneic stem cell transplant recipients.
J Gen Virol
; 96(11): 3373-3381, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26341195
17.
Role of cytomegalovirus (CMV)-specific polyfunctional CD8+ T-cells and antibodies neutralizing virus epithelial infection in the control of CMV infection in an allogeneic stem-cell transplantation setting.
J Gen Virol
; 96(9): 2822-2831, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26025872
18.
Incidence and dynamics of active cytomegalovirus infection in allogeneic stem cell transplant patients according to single nucleotide polymorphisms in donor and recipient CCR5, MCP-1, IL-10, and TLR9 genes.
J Med Virol
; 87(2): 248-55, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25132583
19.
Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia.
J Med Virol
; 87(9): 1601-7, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25802229
20.
Failure of Cytomegalovirus-Specific CD8+ T Cell Levels at Viral DNAemia Onset to Predict the Eventual Need for Preemptive Antiviral Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
J Infect Dis
; 219(9): 1510-1512, 2019 04 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30597050